Stojkovic Marija, Junghanss Thomas, Krause Eric, Davidson Robert N
Section of Clinical Tropical Medicine, Heidelberg University Hospital, Heidelberg, and General Practice, Dreisamstr. 11, Freiburg, Germany.
Int J Dermatol. 2007 Apr;46(4):385-7. doi: 10.1111/j.1365-4632.2007.03153.x.
A 26-year-old man presented to our clinic for advice on treatment options regarding cutaneous leishmaniasis (CL) with multiple lesions. The biopsy revealed Leishmania amastigotes; Leishmania major was identified by polymerase chain reaction (PCR).(11 )Leishmania serology (indirect immunofluorescence test) was positive at 1 : 160 (normal, < or = 1 : 40). Ten weeks earlier, the patient had spent a 1-week biking holiday in central Tunisia. Two weeks after returning to Germany, he noticed the flaring up of multiple insect bites (> 40) contracted in Tunisia on both arms. The lesions increased in size and axillary lymph node enlargement occurred. Some of the nodular lesions disappeared spontaneously and some increased in size and showed central ulceration. When we first saw the patient, he had six lesions on his right arm and one on his left arm. The largest lesion was on the dorsum of the right hand (Fig. 1) and showed an indurated edge and central ulceration. Before starting systemic treatment, the patient decided to wait a few weeks in case spontaneous improvement occurred. However, 8 weeks later, the ulceration had further increased in size (Fig. 2) from a diameter of 2 cm initially to a diameter of 5 cm. Regional lymphatic spread with palpable nodules along the adjacent lymphatic vessel had occurred. With the patient's informed consent, treatment with oral miltefosine, according to his body weight of 96 kg, was started at 50 mg three times daily for 28 days. The treatment was well tolerated without any subjective side-effects reported. Liver enzymes, serum creatinine, and urea were monitored during treatment. There was a mild increase in liver enzymes during the third week of treatment: aspartate aminotransferase (AST), 49 U/L (normal, < 35 U/L); alanine aminotransferase (ALT), 107 U/L (normal, < 45 U/L); this resolved spontaneously. Ten days after completion of treatment, the rolled edge had disappeared and the central ulcer had almost healed (Fig. 3). Figure 4 shows the lesion 5 months after completion of treatment.
一名26岁男性到我们诊所咨询关于多发性皮肤利什曼病(CL)的治疗方案。活检发现利什曼原虫无鞭毛体;通过聚合酶链反应(PCR)鉴定为硕大利什曼原虫。(11)利什曼原虫血清学检查(间接免疫荧光试验)结果为阳性,滴度为1:160(正常范围,≤1:40)。10周前,该患者在突尼斯中部度过了为期1周的骑行假期。回到德国两周后,他注意到在突尼斯双臂上感染的多处(>40处)蚊虫叮咬处出现炎症。皮损面积增大,腋窝淋巴结肿大。一些结节状皮损自行消退,一些则增大并出现中央溃疡。我们初次见到该患者时,他右臂有6处皮损,左臂有1处。最大的皮损位于右手背(图1),表现为硬结边缘和中央溃疡。在开始全身治疗前,患者决定等待几周,看是否会自行好转。然而,8周后,溃疡面积进一步增大(图2),最初直径为2厘米,增大到了5厘米。出现了区域淋巴扩散,沿相邻淋巴管可触及结节。在患者知情同意后,根据其体重96公斤,开始口服米替福新治疗,剂量为每日3次,每次50毫克,共28天。治疗耐受性良好,未报告任何主观副作用。治疗期间监测了肝酶、血清肌酐和尿素。治疗第三周时肝酶有轻度升高:天冬氨酸转氨酶(AST),49 U/L(正常范围,<35 U/L);丙氨酸转氨酶(ALT),107 U/L(正常范围,<45 U/L);之后自行缓解。治疗结束10天后,卷边消失,中央溃疡几乎愈合(图3)。图4显示了治疗结束5个月后的皮损情况。
Int J Dermatol. 2007-4
Clin Exp Dermatol. 2009-7
Trans R Soc Trop Med Hyg. 2006-12
Dtsch Med Wochenschr. 2003-10-2
Acta Trop. 2008-10
Clin Infect Dis. 2004-5-1
Trans R Soc Trop Med Hyg. 2006-7
Cochrane Database Syst Rev. 2017-12-1
Cochrane Database Syst Rev. 2017-11-17
Travel Med Infect Dis. 2017
Open Forum Infect Dis. 2016-2-1
Expert Opin Pharmacother. 2015-2
PLoS Negl Trop Dis. 2011-12-13
Antimicrob Agents Chemother. 2008-8